Consultants Forum Advertise
Subscribe
Close

  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Subscribe Now
Renew

Area Development - Site Selection, Facility Planning and Workforce Development

South Korea-Based UNDBIO Plans Morgantown, West Virginia, Insulin Manufacturing Complex

04/20/2023
UNDBIO, a South Korean pharmaceutical company that provides diabetic care solutions, will establish an insulin manufacturing facility in Morgantown, West Virginia. The $100 million project is expected to create 200 jobs within three years.

The company secured a lease with West Virginia University and will work to receive FDA approval for the product.

"The mission of UNDBIO is to develop and produce state-of-the-art insulin in West Virginia,” UNDBIO Chairman Caleb Jun said. “Our products will save human lives and improve the quality of life for those afflicted with diabetes. We are excited to see West Virginia become a mecca for manufacturing highly advanced insulin to treat diabetic patients around the world."

UNDBIO is the only Korean pharmaceutical company to provide a complete Diabetes care Solution by offering high-quality affordable Insulin, Insulin Analogs to meet the unmet need of diabetes patients.

“I join the Governor in expressing my excitement for this announcement today,” Secretary of the West Virginia Department of Commerce Mitch Carmichael noted. “This announcement, this company, this investment, and the potential for so many jobs for our hardworking West Virginians makes for a very great day. Good things are on the horizon, this is just the beginning!”

Exclusive Research